The Risk-free use of TILDREN hasn't been evaluated in horses a lot less than 4 many years of age. The outcome of bisphosphonates to the skeleton of increasing horses has not been analyzed; even so, bisphosphonates inhibit osteoclast activity which impacts bone turnover and could influence bone development. Do not use in horses with impaired rena